Effects of Electroacupuncture Treatment on Bone Cancer Pain Model with Morphine Tolerance.
Objective. To explore the efficacy of electroacupuncture treatment in cancer induced bone pain (CIBP) rat model with morphine tolerance and explore changes of calcitonin-gene related peptide (CGRP) expression in dorsal root ganglion (DRG). Methods. Forty SD rats were divided into five groups: sham, CIBP (B), CIBP + morphine (BM), CIBP + electroacupuncture (BE), and CIBP + morphine + electroacupuncture (BME). B, BM, BE, and BME groups were prepared CIBP model. The latter three groups then accepted morphine, electroacupuncture, and morphine combined electroacupuncture, separately, nine days consecutively (M1 to M9). Mechanical withdraw threshold (MWT) was evaluated. Results. BE group only had differences in M1, M2, and M3 compared to B group (P < 0.01). From M5, BM group showed significantly decreased MWT. Electroacupuncture could obtain analgesic effects only at early stage (M1 to M5). From M5 to M9, BME had the differences with BM group (P < 0.01). IOD value of CGRP in BM and BME was substantially less than in B group. CGRP in BME was significantly lower than that in BM group (P < 0.01). Conclusion. When used in combination with electroacupuncture, morphine could result in improving analgesic effects and reducing tolerance. CGRP may be associated with pain behaviors.
National Pain Management and Research Center, China-Japan Friendship Hospital, Beijing, China.
Lei
0000-0003-4617-9002
L
Sima
National Pain Management and Research Center, China-Japan Friendship Hospital, Beijing, China.
Bifa
B
Fan
National Pain Management and Research Center, China-Japan Friendship Hospital, Beijing, China.
Longtao
L
Yan
National Pain Management and Research Center, China-Japan Friendship Hospital, Beijing, China.
Yuan
Y
Shui
Evid Based Complement Alternat Med. 2014;2014:191347
25383081
Peptides. 2005 Aug;26(8):1346-55
16042975
Evid Based Complement Alternat Med. 2016;2016:2126416
27073400
Neuroscience. 2007 Jun 8;146(4):1795-807
17467916
Am J Chin Med. 2015;43(1):57-70
25640847
Evid Based Complement Alternat Med. 2013;2013:294091
24078821
J Pain Symptom Manage. 2001 Feb;21(2):144-50
11226765
BMC Complement Altern Med. 2014 Aug 26;14:316
25158599
Anesth Analg. 2005 Sep;101(3):728-734
16115983
Br J Pharmacol. 2000 Nov;131(5):875-84
11053206
Evid Based Complement Alternat Med. 2016;2016:1720239
26977172
Cochrane Database Syst Rev. 2015 Oct 15;(10):CD007753
26468973
Neural Regen Res. 2014 Jul 15;9(14):1365-70
25221593
Neuroscience. 2000;98(3):585-98
10869852
Evid Based Complement Alternat Med. 2011;2011:671043
21799687